Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes
Clinical trial NCT03334214 · COMPLETED
Trial details
- NCT number
- NCT03334214
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2018-11-28
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.